• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价 MAGE-D4 表达在日本肝癌患者中的意义。

Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.

机构信息

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

J Surg Oncol. 2013 Dec;108(8):557-62. doi: 10.1002/jso.23440. Epub 2013 Sep 20.

DOI:10.1002/jso.23440
PMID:24068544
Abstract

BACKGROUND AND OBJECTIVES

Though Melanoma-associated antigen (MAGE) family genes have received lots of attention as cancer-related genes and targets for immunotherapy, MAGE-D4 expression in hepatocellular carcinoma (HCC) has not yet been evaluated.

METHODS

MAGE-D4 mRNA expression was assayed in nine HCC cell lines and 94 HCC surgical specimens obtained from Japanese patients by quantitative real-time reverse transcription polymerase chain reaction, and the correlations between MAGE-D4 mRNA expression and clinicopathological factors were evaluated. The expression and distribution of MAGE-D4b protein were evaluated immunohistochemically.

RESULTS

MAGE-D4 mRNA was overexpressed in five of nine HCC cell lines and 34 of 94 primary HCCs (36.2%). Median overall survival (14.8 vs. 118 months, P < 0.001) and relapse-free survival (2.7 vs. 18.3 months, P < 0.001) were significantly shorter in patients with high than with low-moderate MAGE-D4 expression. Multivariate analysis for overall survival showed that MAGE-D4 overexpression was independently prognostic for survival (hazard ratio 2.88, P = 0.009) and significantly associated with high alpha-fetoprotein concentration (P < 0.001), poor tumor differentiation (P = 0.003) and vascular invasion (P = 0.021). MAGE-D4b protein expression patterns were consistent with those of MAGE-D4 mRNA.

CONCLUSIONS

Overexpression of MAGE-D4 may be a predictive marker of early recurrence and mortality in patients with HCC.

摘要

背景与目的

尽管黑色素瘤相关抗原(MAGE)家族基因作为癌症相关基因和免疫治疗靶点受到了广泛关注,但 MAGE-D4 在肝细胞癌(HCC)中的表达尚未得到评估。

方法

通过实时定量逆转录聚合酶链反应(qRT-PCR)检测 9 种 HCC 细胞系和 94 例日本 HCC 手术标本中 MAGE-D4mRNA 的表达,并评估 MAGE-D4mRNA 表达与临床病理因素的相关性。采用免疫组织化学法评估 MAGE-D4b 蛋白的表达和分布。

结果

MAGE-D4mRNA 在 9 种 HCC 细胞系中的 5 种和 94 例原发性 HCC 中的 34 例中过表达(36.2%)。高表达 MAGE-D4 的患者中位总生存期(14.8 个月比 118 个月,P<0.001)和无复发生存期(2.7 个月比 18.3 个月,P<0.001)明显更短。总生存的多因素分析显示,MAGE-D4 过表达是独立的生存预后因素(危险比 2.88,P=0.009),且与高甲胎蛋白浓度(P<0.001)、肿瘤分化差(P=0.003)和血管侵犯(P=0.021)显著相关。MAGE-D4b 蛋白的表达模式与 MAGE-D4mRNA 的表达模式一致。

结论

MAGE-D4 的过表达可能是 HCC 患者早期复发和死亡的预测标志物。

相似文献

1
Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.评价 MAGE-D4 表达在日本肝癌患者中的意义。
J Surg Oncol. 2013 Dec;108(8):557-62. doi: 10.1002/jso.23440. Epub 2013 Sep 20.
2
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?肝细胞癌患者外周血中黑色素瘤抗原-1 mRNA与甲胎蛋白mRNA水平联合检测:术后复发或转移的预测指标?
ANZ J Surg. 2009 Jan-Feb;79(1-2):62-9. doi: 10.1111/j.1445-2197.2008.04801.x.
3
Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.黑色素瘤相关抗原D4的过表达是食管鳞状细胞癌的一个独立预后因素。
Dis Esophagus. 2015 Feb-Mar;28(2):188-95. doi: 10.1111/dote.12156. Epub 2013 Oct 21.
4
Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.神经胶质抗原2在肝细胞癌中的过表达预示预后不良。
World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.
5
Expression of MAGE genes and survival in patients with hepatocellular carcinoma.MAGE基因表达与肝细胞癌患者的生存情况
Int J Oncol. 1999 Dec;15(6):1227-32. doi: 10.3892/ijo.15.6.1227.
6
High expression and frequently humoral immune response of melanoma-associated antigen D4 in glioma.黑色素瘤相关抗原D4在胶质瘤中的高表达及频繁的体液免疫反应
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2350-60. eCollection 2014.
7
Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.磷脂酰肌醇4激酶IIIα的过表达与人类肝细胞癌的未分化状态及不良预后相关。
BMC Cancer. 2014 Jan 6;14:7. doi: 10.1186/1471-2407-14-7.
8
L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.L1 细胞黏附分子在肝细胞癌中的过表达与肿瘤的进展和患者的不良预后相关。
Diagn Pathol. 2012 Aug 13;7:96. doi: 10.1186/1746-1596-7-96.
9
Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.前列腺肿瘤过表达蛋白1是肝细胞癌进展和患者总体生存的一种新型预后标志物。
Medicine (Baltimore). 2015 Jan;94(4):e423. doi: 10.1097/MD.0000000000000423.
10
Overexpression of MAGE-D4 in colorectal cancer is a potentially prognostic biomarker and immunotherapy target.MAGE-D4在结直肠癌中的过表达是一种潜在的预后生物标志物和免疫治疗靶点。
Int J Clin Exp Pathol. 2014 Jun 15;7(7):3918-27. eCollection 2014.

引用本文的文献

1
Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma.与表观遗传药物联合治疗通过上调胶质瘤中MAGE-D4的表达增强MAGE-D4肽特异性T细胞的抗肿瘤活性。
Front Oncol. 2022 Aug 3;12:873639. doi: 10.3389/fonc.2022.873639. eCollection 2022.
2
Prognostic and clinicopathological value of melanoma-associated antigen D4 in patients with glioma.黑色素瘤相关抗原D4在胶质瘤患者中的预后及临床病理价值
Oncol Lett. 2018 Apr;15(4):4151-4160. doi: 10.3892/ol.2018.7884. Epub 2018 Jan 26.
3
An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma.
用于预测肝细胞癌患者根治性肝切除术后长期生存的综合多基因表达谱
Oncotarget. 2017 Aug 19;8(41):71070-71079. doi: 10.18632/oncotarget.20369. eCollection 2017 Sep 19.
4
NRAGE promotes the malignant phenotype of hepatocellular carcinoma.神经生长调控蛋白(NRAGE)促进肝细胞癌的恶性表型。
Oncol Lett. 2016 Mar;11(3):1847-1854. doi: 10.3892/ol.2016.4120. Epub 2016 Jan 15.
5
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.肝细胞癌发生与进展的遗传和表观遗传方面
World J Gastroenterol. 2015 Oct 7;21(37):10584-97. doi: 10.3748/wjg.v21.i37.10584.
6
Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.利用蛋白质组学方法鉴别胆管癌与良性胆道疾病的新型血清生物标志物
Dis Markers. 2015;2015:105358. doi: 10.1155/2015/105358. Epub 2015 Apr 28.
7
Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy.黑色素瘤相关抗原D2的异常表达可作为肝细胞癌根治性肝切除术后预后的指标。
Oncol Lett. 2015 Mar;9(3):1201-1206. doi: 10.3892/ol.2014.2823. Epub 2014 Dec 23.
8
Overexpression of MAGE-D4 in colorectal cancer is a potentially prognostic biomarker and immunotherapy target.MAGE-D4在结直肠癌中的过表达是一种潜在的预后生物标志物和免疫治疗靶点。
Int J Clin Exp Pathol. 2014 Jun 15;7(7):3918-27. eCollection 2014.
9
High expression and frequently humoral immune response of melanoma-associated antigen D4 in glioma.黑色素瘤相关抗原D4在胶质瘤中的高表达及频繁的体液免疫反应
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2350-60. eCollection 2014.
10
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.具有预后和治疗潜力的新型肝细胞癌分子。
World J Gastroenterol. 2014 Feb 7;20(5):1268-88. doi: 10.3748/wjg.v20.i5.1268.